Cited by 1,524Viral-associated cancers and disordersTransplantation: Methods and OutcomesRenal Transplantation Outcomes and Treatments

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

Open access

Engels, Eric A., Pfeiffer, Ruth M., Fraumeni, Joseph F., Kasiske, Bertram L., Israni, Ajay K., Snyder, Jon J., Wolfe, Robert A., Goodrich, Nathan P., Bayakly, A. Rana, Clarke, Christina A., Copeland, Glenn, Finch, Jack L., Fleissner, Mary Lou, Goodman, Marc T., Kahn, Amy, Koch, Lori, Lynch, Charles F., Madeleine, Margaret M., Pawlish, Karen, Rao, Chandrika, Williams, Melanie A., Castenson, David, Curry, Michael, Parsons, Ruth, Fant, Gregory, Lin, Monica·2011·JAMA

DOI 10.1001/jama.2011.1592PMC PMC3310893

Open this paper in CoChat — free account

Abstract

CONTEXT: Solid organ transplant recipients have elevated cancer risk due to immunosuppression and oncogenic viral infections. Because most prior research has concerned kidney recipients, large studies that include recipients of differing organs can inform cancer etiology. OBJECTIVE: To describe the overall pattern of cancer following solid organ transplantation. DESIGN, SETTING, AND PARTICIPANTS: Cohort study using linked data on solid organ transplant recipients from the US Scientific Registry of Transplant Recipients (1987-2008) and 13 state and regional cancer registries. MAIN OUTCOME MEASURES: Standardized incidence ratios (SIRs) and excess absolute risks (EARs) assessing relative and absolute cancer risk in transplant recipients compared with the general population. RESULTS: The registry linkages yielded data on 175,732 solid organ transplants (58.4% for kidney, 21.6% for liver, 10.0% for heart, and 4.0% for lung). The overall cancer risk was elevated with 10,656 cases and an incidence of 1375 per 100,000 person-years (SIR, 2.10 [95% CI, 2.06-2.14]; EAR, 719.3 [95% CI, 693.3-745.6] per 100,000 person-years). Risk was increased for 32 different malignancies, some related to known infections (eg, anal cancer, Kaposi sarcoma) and others unrelated (eg, melanoma, thyroid and lip cancers). The most common malignancies with elevated risk were non-Hodgkin lymphoma (n = 1504; incidence: 194.0 per 100,000 person-years; SIR, 7.54 [95% CI, 7.17-7.93]; EAR, 168.3 [95% CI, 158.6-178.4] per 100,000 person-years) and cancers of the lung (n = 1344; incidence: 173.4 per 100,000 person-years; SIR, 1.97 [95% CI, 1.86-2.08]; EAR, 85.3 [95% CI, 76.2-94.8] per 100,000 person-years), liver (n = 930; incidence: 120.0 per 100,000 person-years; SIR, 11.56 [95% CI, 10.83-12.33]; EAR, 109.6 [95% CI, 102.0-117.6] per 100,000 person-years), and kidney (n = 752; incidence: 97.0 per 100,000 person-years; SIR, 4.65 [95% CI, 4.32-4.99]; EAR, 76.1 [95% CI, 69.3-83.3] per 100,000 person-years). Lung cancer risk was most elevated in lung recipients (SIR, 6.13 [95% CI, 5.18-7.21]) but also increased among other recipients (kidney: SIR, 1.46 [95% CI, 1.34-1.59]; liver: SIR, 1.95 [95% CI, 1.74-2.19]; and heart: SIR, 2.67 [95% CI, 2.40-2.95]). Liver cancer risk was elevated only among liver recipients (SIR, 43.83 [95% CI, 40.90-46.91]), who manifested exceptional risk in the first 6 months (SIR, 508.97 [95% CI, 474.16-545.66]) and a 2-fold excess risk for 10 to 15 years thereafter (SIR, 2.22 [95% CI, 1.57-3.04]). Among kidney recipients, kidney cancer risk was elevated (SIR, 6.66 [95% CI, 6.12-7.23]) and bimodal in onset time. Kidney cancer risk also was increased in liver recipients (SIR, 1.80 [95% CI, 1.40-2.29]) and heart recipients (SIR, 2.90 [95% CI, 2.32-3.59]). CONCLUSION: Compared with the general population, recipients of a kidney, liver, heart, or lung transplant have an increased risk for diverse infection-related and unrelated cancers.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jama.2011.1592

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Preoperative assessment of liver function: a comparison of 99mTc‐Mebrofenin scintigraphy with indocyanine green clearance test
Erdogan, D., Heijnen, B. H. M., Bennink, R. J., Kok, M., Dinant, S., Straatsburg, I. H., Gouma, D. J., & van Gulik, T. M. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.00901.x · Cited by 11,656
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S. A., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,173
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,602
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
Grulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61050-2 · Cited by 2,321
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.
Breslow, N. E., & Day, N. E. (1987) · PubMed · Cited by 1,684
Overdiagnosis in Cancer
Welch, H. G., & Black, W. C. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq099 · Cited by 1,627
The design and analysis of cohort studies
Breslow, N. E., & Day, N. E. (1987) · International Agency for Research on Cancer eBooks · Cited by 1,312

Flagged first, then by citations

Show all 43 references

Sorted by citations

Items 101–200 of 1,000

The increasing incidence of anal cancer: can it be explained by trends in risk groups?
van der Zee, R. P., Richel, O., de Vries, H. J. C., & Prins, J. M. (2013) · PubMed · Cited by 94
Tacrolimus and the Risk of Solid Cancers After Liver Transplant: A Dose Effect Relationship
Carenco, C., Assénat, E., Faure, S., Duny, Y., Danan, G., Bismuth, M., Herrero, A., Jung, B., Bedoya, J. U., Jaber, S., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13018 · Cited by 94
Association Between Atopic Eczema and Cancer in England and Denmark
Mansfield, K. E., Schmidt, S. A. J., Darvalics, B., Mulick, A. R., Abuabara, K., Wong, A. Y. S., Sørensen, H. T., Smeeth, L. L., Bhaskaran, K., dos‐Santos‐Silva, I., et al. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.1948 · Cited by 93
Immune checkpoint inhibitors in kidney transplant recipients: a multicentre, single-arm, phase 1 study
Carroll, R. P., Boyer, M. J., Gebski, V., Hockley, B., Johnston, J. K., Kireta, S., Tan, H., Taylor, A., Wyburn, K., & Zalcberg, J. R. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00368-0 · Cited by 93
Effects of Recipient Age and Diagnosis on Health-related Quality-of-Life Benefit of Lung Transplantation
Singer, L. G., Chowdhury, N., Faughnan, M. E., Granton, J. T., Keshavjee, S. H., Marras, T. K., Tullis, D. E., Waddell, T. K., & TOMLINSON, G. A. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0126oc · Cited by 91
Risk of Breast, Prostate, and Colorectal Cancer Diagnoses Among HIV-Infected Individuals in the United States
Coghill, A. E., Engels, E. A., Schymura, M. J., Mahale, P. S., & Shiels, M. S. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy010 · Cited by 91
Self-citation
Association of Antibody Induction Immunosuppression With Cancer After Kidney Transplantation
Hall, E. C., Engels, E. A., Pfeiffer, R. M., & Segev, D. L. (2014) · Transplantation · doi:10.1097/tp.0000000000000449 · Cited by 90
Self-citation
The Changing Epidemiology of Posttransplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Recipients Over 30 Years
Peters, A., Akinwumi, M. S., Cervera, C., Mabilangan, C., Ghosh, S., Lai, R. L., Iafolla, M. A. J., Doucette, K. E., & Preiksaitis, J. K. (2018) · Transplantation · doi:10.1097/tp.0000000000002146 · Cited by 88
Adverse Childhood Experiences and the Presence of Cancer Risk Factors in Adulthood: A Scoping Review of the Literature From 2005 to 2015
Ports, K. A., Holman, D. M., Guinn, A. S., Pampati, S., Dyer, K. E., Merrick, M. T., Lunsford, N. B., & Metzler, M. M. (2018) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2018.10.009 · Cited by 93
Cancer risk and mortality after solid organ transplantation: A population‐based 30‐year cohort study in Finland
Friman, T., Jäämaa‐Holmberg, S., Åberg, F. O., Helanterä, I., Halme, M. K., Pentikäinen, M. O., Nordin, A. J., Lemström, K., Jahnukainen, T., Räty, R., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.33934 · Cited by 87
The Burden of HPV-Associated Anogenital Cancers
Wakeham, K., & Kavanagh, K. (2014) · Current Oncology Reports · doi:10.1007/s11912-014-0402-4 · Cited by 89
Incidence of Primary and Second Cancers in Renal Transplant Recipients: A Multicenter Cohort Study
Tessari, G., Naldi, L., Boschiero, L., Minetti, E., Sandrini, S., Nacchia, F., Valerio, F., Rugiu, C., Sassi, F., Gotti, E., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04294.x · Cited by 86
Lung cancer: potential targets for immunotherapy
Tartour, É., & Zitvogel, L. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70159-0 · Cited by 87
De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management—Guidelines From the ILTS-SETH Consensus Conference
Colmenero, J., Tabrizian, P., Bhangui, P., Pinato, D. J., Rodríguez‐Perálvarez, M., Sapisochín, G., Bhoori, S., Pascual, S., Senzolo, M., Al‐Adra, D. P., et al. (2021) · Transplantation · doi:10.1097/tp.0000000000003998 · Cited by 88
Immune Checkpoint Inhibitor Use in Solid Organ Transplant Recipients: A Systematic Review
Portuguese, A. J., Tykodi, S. S., Blosser, C. D., Gooley, T., Thompson, J. A., & Hall, E. T. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.7009 · Cited by 85
Cancer Risks in Solid Organ Transplant Recipients: Results from a Comprehensive Analysis of 72 Cohort Studies
Huo, Z., Li, C., Xu, X. Y., Ge, F., Wang, R., Wen, Y., Peng, H., Wu, X., Liang, H., Peng, G., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1848068 · Cited by 85
Acute and Chronic Allograft Dysfunction in Kidney Transplant Recipients
Goldberg, R. J., Weng, F. L., & Kandula, P. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.01.002 · Cited by 86
A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival
Kinch, A., Baecklund, E., Backlin, C., Ekman, T., Molin, D. L., Tufveson, G., Fernberg, P., Sundström, C., Pauksens, K., & Enblad, G. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.844853 · Cited by 83
Urologic malignancies in kidney transplantation
Hickman, L. A., Sawinski, D. L., Guzzo, T. J., & Locke, J. E. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14533 · Cited by 82
Transplant rejections associated with immune checkpoint inhibitors: A pharmacovigilance study and systematic literature review
Nguyen, L. S., Ortuno, S., Lebrun‐Vignes, B., Johnson, D. B., Moslehi, J. J., Hertig, A., & Salem, J. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.01.038 · Cited by 81
Adapted Treatment of Epstein–Barr Virus Infection to Prevent Posttransplant Lymphoproliferative Disorder After Heart Transplantation
Choquet, S., Varnous, S., Deback, C., Golmard, J., & Leblond, V. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12640 · Cited by 81
Heart Transplant Survival Outcomes for Adriamycin-Dilated Cardiomyopathy
Lenneman, A., Wang, L. A., Wigger, M., Frangoul, H., Harrell, F. E., Silverstein, C. A., Sawyer, D. B., & Lenneman, C. G. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.10.048 · Cited by 80
Systematic review of melanoma incidence and prognosis in solid organ transplant recipients
Dahlke, E. J., Murray, C., Kitchen, J., & Chan, A. (2014) · Transplantation Research · doi:10.1186/2047-1440-3-10 · Cited by 80
Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?
De Bruyn, P., Van Gestel, D., Ost, P., Kruse, V., Brochez, L., Van Vlierberghe, H., Devresse, A., del Marmol, V., Le Moine, A., & Aspeslagh, S. (2019) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000505 · Cited by 79
Epidemiologic perspectives on immunosuppressed populations and the immunosurveillance and immunocontainment of cancer
Engels, E. A. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15495 · Cited by 82
Self-citation
Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN)
Launay‐Vacher, V., Aapro, M., de Castro, G., Cohen, E. E. W., Deray, G., Dooley, M., Humphreys, B. D., Lichtman, S. M., Rey, J., Scotté, F., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv136 · Cited by 79
Cancer Risk After Pediatric Solid Organ Transplantation
Yanik, E. L., Smith, J. M., Shiels, M. S., Clarke, C. A., Lynch, C. F., Kahn, A. R., Koch, L., Pawlish, K. S., & Engels, E. A. (2017) · PEDIATRICS · doi:10.1542/peds.2016-3893 · Cited by 81
Self-citation
The safety of calcineurin inhibitors for kidney-transplant patients
Malvezzi, P., & Rostaing, L. P. E. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1083974 · Cited by 78
Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control
Connolly, K., Manders, P., Earls, P., & Epstein, R. J. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.08.005 · Cited by 79
Contribution of HIV infection to mortality among cancer patients in Uganda
Coghill, A. E., Newcomb, P. A., Madeleine, M. M., Richardson, B. A., Mutyaba, I., Okuku, F. M., Phipps, W. T., Wabinga, H., Orem, J., & Casper, C. (2013) · AIDS · doi:10.1097/01.aids.0000433236.55937.cb · Cited by 78
Self-citation
An update on cancer after kidney transplantation
Cheung, C. Y., & Tang, S. C. W. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy262 · Cited by 78
Renal Cell Carcinoma and Kidney Transplantation: A Narrative Review
Dahle, D. O., Skauby, M., Langberg, C. W., Brabrand, K., Wessel, N., & Midtvedt, K. (2021) · Transplantation · doi:10.1097/tp.0000000000003762 · Cited by 79
Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis
Wilton, K. M., & Matteson, E. L. (2017) · Rheumatology and Therapy · doi:10.1007/s40744-017-0064-4 · Cited by 78
Skin Cancer Following Solid Organ Transplantation: A Review of Risk Factors and Models of Care
Howard, M. D., Su, J. C., & Chong, A. H. (2018) · American Journal of Clinical Dermatology · doi:10.1007/s40257-018-0355-8 · Cited by 79
Global trends in anal cancer incidence and mortality
Mignozzi, S., Santucci, C., Malvezzi, M., Levi, F., Vecchia, C. L., & Negri, E. (2023) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000842 · Cited by 77
Complications of Immunosuppressive Therapy in Solid Organ Transplantation
Katabathina, V. S., Menias, C. O., Pickhardt, P. J., Lubner, M. G., & Prasad, S. R. (2015) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2015.09.009 · Cited by 80
Risk of Kaposi sarcoma after solid organ transplantation in the United States
Cahoon, E. K., Linet, M. S., Clarke, C. A., Pawlish, K. S., Engels, E. A., & Pfeiffer, R. M. (2018) · International Journal of Cancer · doi:10.1002/ijc.31735 · Cited by 77
Self-citation
Neoplastic disease after liver transplantation: Focus onde novoneoplasms
Burra, P. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i29.8753 · Cited by 76
Regulatory T cells that co-express RORγt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer
Chellappa, S., Hugenschmidt, H., Hagness, M., Line, P., Labori, K. J., Wiedswang, G., Taskén, K., & Aandahl, E. M. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1102828 · Cited by 76
Sepsis and Risk of Cancer Among Elderly Adults in the United States
Liu, Z., Mahale, P. S., & Engels, E. A. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy530 · Cited by 79
Self-citation
Epidemiology of Kaposi’s Sarcoma
Grabar, S., & Costagliola, D. G. (2021) · Cancers · doi:10.3390/cancers13225692 · Cited by 75
Systematic Review of the Safety of Immune Checkpoint Inhibitors Among Kidney Transplant Patients
Manohar, S., Thongprayoon, C., Cheungpasitporn, W., Markovic, S. N., & Herrmann, S. M. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.11.015 · Cited by 74
Acute Rejection, T-Cell–Depleting Antibodies, and Cancer After Transplantation
Lim, W. H., Turner, R. M., Chapman, J. R., Ma, M. K. M., Webster, A. C., Craig, J. C., & Wong, G. (2014) · Transplantation · doi:10.1097/01.tp.0000442773.38510.32 · Cited by 74
Implication of human herpesviruses in oncogenesis through immune evasion and supression
Alibek, K., Baiken, Y., Kakpenova, A., Mussabekova, A., Zhussupbekova, S., Akan, M., & Sultankulov, B. (2014) · Infectious Agents and Cancer · doi:10.1186/1750-9378-9-3 · Cited by 74
De novo malignancies after liver transplantation: The effect of immunosuppressionn-personal data and review of literature
Manzia, T. M., Angelico, R., Gazia, C., Lenci, I., Milana, M., Ademoyero, O. T., Pedini, D., Toti, L., Spada, M., Tisone, G., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i35.5356 · Cited by 74
Prevalence of HIV Infection among U.S. Hodgkin Lymphoma Cases
Shiels, M. S., Koritzinsky, E. H., Clarke, C. A., Suneja, G., Morton, L. M., & Engels, E. A. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0865 · Cited by 73
Self-citation
Solid Renal Masses in Transplanted Allograft Kidneys: A Closer Look at the Epidemiology and Management
Griffith, J. J., Amin, K. A., Waingankar, N., Lerner, S., DELANEY, V. B., Ames, S. A., Badani, K. K., Palese, M., & Mehrazin, R. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14366 · Cited by 73
How to improve long‐term outcome after liver transplantation?
Durand, F. (2018) · Liver International · doi:10.1111/liv.13651 · Cited by 73
Cancer vaccines: past, present and future; a review article
Grimmett, E., Al-Share, B. A., Alkassab, M. B., Zhou, R. W., Desai, A., Rahim, M. M. A., & Woldie, I. (2022) · Discover Oncology · doi:10.1007/s12672-022-00491-4 · Cited by 77
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0
Pavlick, A. C., Ariyan, C. E., Buchbinder, E. I., Davar, D., Gibney, G. T., Hamid, O., Hieken, T. J., Izar, B., Johnson, D. B., Kulkarni, R. P., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-006947 · Cited by 74
Aging and the immune response to organ transplantation
Colvin, M. M., Smith, C. A., Tullius, S. G., & Goldstein, D. R. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90601 · Cited by 74
Immunomodulatory plasticity of mesenchymal stem cells: a potential key to successful solid organ transplantation
Kaundal, U., Bagai, U., & Rakha, A. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1403-0 · Cited by 72
Antibody Conditioning Enables MHC-Mismatched Hematopoietic Stem Cell Transplants and Organ Graft Tolerance
George, B. M., Kao, K. S., Kwon, H.-S., Velasco, B. J., Poyser, J., Chen, A. C., Le, A., Chhabra, A., Burnett, C. E., Cajuste, D., et al. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.05.018 · Cited by 72
Immunity in Head and Neck Cancer
Schoenfeld, J. D. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0205 · Cited by 70
New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin®) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity
Mohty, M., Bacigalupo, A. P., Saliba, F., Zuckermann, A. O., Morélon, E., & Lebranchu, Y. (2014) · Drugs · doi:10.1007/s40265-014-0277-6 · Cited by 70
Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeutics
Razavi, P., Rand, K. A., Cozen, W., Chanan-Khan, A. A., Usmani, S. Z., & Ailawadhi, S. (2013) · Blood Cancer Journal · doi:10.1038/bcj.2013.19 · Cited by 71
Polycystic Kidney Disease and Cancer after Renal Transplantation
Wetmore, J. B., Calvet, J. P., Yu, A. S. L., Lynch, C. F., Wang, C. J., Kasiske, B. L., & Engels, E. A. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013101122 · Cited by 70
Self-citation
The evolutionary ecology of transmissible cancers
Újvári, B., Gatenby, R. A., & Frédéric Thomas, A. (2016) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2016.02.005 · Cited by 77
Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients
Serée, O., Altieri, M. H., Guillaume, E., Mil, R. D., Lobbedez, T., Robinson, P., Segol, P., Salamé, E., Abergel, A., Boillot, O., et al. (2018) · Liver Transplantation · doi:10.1002/lt.25310 · Cited by 69
Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging Issue
Aguirre, L. E., Guzman, M. E., Lopes, G., & Hurley, J. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0195 · Cited by 68
Predictors of Cancer Risk in the Long-Term Solid-Organ Transplant Recipient
Sherston, S., Carroll, R. P., Harden, P., & Wood, K. J. (2013) · Transplantation · doi:10.1097/01.tp.0000436907.56425.5c · Cited by 68
De Novo Malignancies After Transplantation
Doycheva, I., Amer, S., & Watt, K. D. S. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.01.006 · Cited by 66
Heart transplantation: review
Mangini, S., Alves, B. R., Silvestre, O. M., Pires, P. V., Pires, L. J. T., Curiati, M. N. C., & Bacal, F. (2015) · Einstein (São Paulo) · doi:10.1590/s1679-45082015rw3154 · Cited by 73
Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update
Holdaas, H., SIMONE, P. D., & Zuckermann, A. O. (2016) · Journal of Transplantation · doi:10.1155/2016/4369574 · Cited by 68
Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients
Yanik, E. L., Gustafson, S. K., Kasiske, B. L., Israni, A. K., Snyder, J. J., Hess, G. P., Engels, E. A., & Segev, D. L. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12969 · Cited by 65
Self-citation
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report
Morton, L. M., Saber, W., Baker, K. S., Barrett, A. J., Bhatia, S., Engels, E. A., Gadalla, S. M., Kleiner, D. E., Pavletic, S. Z., & Burns, L. J. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.09.005 · Cited by 68
Self-citation
Immune checkpoint inhibitor therapy in a liver transplant recipient with a rare subtype of melanoma: a case report and literature review
Kuo, J. C.-Y., Lilly, L., & Hogg, D. (2017) · Melanoma Research · doi:10.1097/cmr.0000000000000410 · Cited by 65
T cell immune deficiency rather than chromosome instability predisposes patients with short telomere syndromes to squamous cancers
Schratz, K. E., Flasch, D. A., Atik, C. C., Cosner, Z. L., Blackford, A. L., Yang, W., Gable, D. L., Vellanki, P. J., Xiang, Z., Gaysinskaya, V. A., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.03.005 · Cited by 64
Incidence, risk factors and outcomes ofde novomalignancies post liver transplantation
Mukthinuthalapati, P. K. V. V., Gotur, R., & Ghabril, M. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i12.533 · Cited by 64
Posttransplantation Lymphoproliferative Disease: Proposed Imaging Classification
Camacho, J. C., Moreno, C. C., Harri, P. A., Aguirre, D. A., Torres, W. E., & Mittal, P. (2014) · Radiographics · doi:10.1148/rg.347130130 · Cited by 63
Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database
Zhou, J., Hu, Z., Zhang, Q., Li, Z., Xiang, J., Yan, S., Wu, J., Zhang, M., & Zheng, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155179 · Cited by 63
Cancer risk among lung transplant recipients with cystic fibrosis
Fink, A. K., Yanik, E. L., Marshall, B. C., Wilschanski, M. A., Lynch, C. F., Austin, A. A., Copeland, G. E., Safaeian, M., & Engels, E. A. (2016) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2016.07.011 · Cited by 63
Self-citation
Restoration of Thymus Function with Bioengineered Thymus Organoids
Tajima, A., Pradhan, I., Trucco, M., & Fan, Y. (2016) · Current Stem Cell Reports · doi:10.1007/s40778-016-0040-x · Cited by 65
Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors
Carenco, C., Faure, S., Herrero, A., Assénat, E., Duny, Y., Danan, G., Bismuth, M., Chanques, G., Bedoya, J. U., Jaber, S., et al. (2014) · Liver International · doi:10.1111/liv.12758 · Cited by 61
Central Nervous System Syndromes in Solid Organ Transplant Recipients
Wright, A. J., & Fishman, J. A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu428 · Cited by 61
Increased Risk of Melanoma in Organ Transplant Recipients: Systematic Review and Meta-analysis of Cohort Studies
Green, A. C., & Olsen, C. M. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-2148 · Cited by 61
Primary central nervous system post-transplant lymphoproliferative disorders: the spectrum of imaging appearances and differential
White, M. L., Moore, D. W., Zhang, Y., Keiper, M. D., Greiner, T. C., & Bierman, P. J. (2019) · Insights into Imaging · doi:10.1186/s13244-019-0726-6 · Cited by 60
Changes in cancer incidence and outcomes among kidney transplant recipients in the United States over a thirty-year period
Blosser, C. D., Haber, G. B., & Engels, E. A. (2020) · Kidney International · doi:10.1016/j.kint.2020.10.018 · Cited by 61
Self-citation
Incidence of Malignancies in Patients Treated With Sirolimus Following Heart Transplantation
Asleh, R., Clavell, A. L., Pereira, N. L., Smith, B. H., Briasoulis, Α., Alnsasra, H., Kremers, W. K., Habermann, T. M., Otley, C. C., Li, X., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.499 · Cited by 62
New Insights into the Epidemiology of Vulvar Cancer: Systematic Literature Review for an Update of Incidence and Risk Factors
Bucchi, L., Pizzato, M., Rosso, S., & Ferretti, S. (2022) · Cancers · doi:10.3390/cancers14020389 · Cited by 59
Inhibitors of mTOR and Risks of Allograft Failure and Mortality in Kidney Transplantation
Isakova, T., Xie, H.-T., Messinger, S., Cortazar, F. B., Scialla, J. J., Guerra, G., Contreras, G. N., Roth, D., Burke, G. W., Molnar, M. Z., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04281.x · Cited by 59
Risk of myeloid neoplasms after solid organ transplantation
Morton, L. M., Gibson, T. M., Clarke, C. A., Lynch, C. F., Anderson, L. A., Pfeiffer, R. M., Landgren, O., Weisenburger, D. D., & Engels, E. A. (2014) · Leukemia · doi:10.1038/leu.2014.132 · Cited by 58
Self-citation
International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20-Positive B Cell PTLD: Clues From the PTLD-1 Trial
Trappe, R. U., Choquet, S., Dierickx, D., Mollee, P. N., Zaucha, J. M., Dreyling, M. H., Dührsen, U., Tarella, C., Shpilberg, O., Sender, M., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13086 · Cited by 58
Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study
Dharnidharka, V. R., Schnitzler, M. A., Chen, J., Brennan, D. C., Axelrod, D. A., Segev, D. L., Schechtman, K. B., Zheng, J., & Lentine, K. L. (2016) · Transplant International · doi:10.1111/tri.12850 · Cited by 59
Reactivation of Latent HPV Infections After Renal Transplantation
Hinten, F., Hilbrands, L. B., Meeuwis, K. A. P., IntHout, J., Quint, W. G. V., Hoitsma, A. J., Massuger, L. F. A. G., Melchers, W. J. G., & de Hullu, J. A. (2016) · American Journal of Transplantation · doi:10.1111/ajt.14181 · Cited by 57
Epstein–Barr virus‐associated smooth muscle tumors after kidney transplantation: treatment and outcomes in a single center
Tan, C. S., Loh, H., Foo, M. W. Y., Choong, L. H. L., Wong, K. S., & Kee, T. Y. S. (2013) · Clinical Transplantation · doi:10.1111/ctr.12139 · Cited by 56
Treatment for presumed BK polyomavirus nephropathy and risk of urinary tract cancers among kidney transplant recipients in the United States
Gupta, G., Kuppachi, S. C., Kalil, R. S., Buck, C. B., Lynch, C. F., & Engels, E. A. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14530 · Cited by 56
Self-citation
Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients
Bhat, M., Mara, K. C., Dierkhising, R., & Watt, K. D. S. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.04.025 · Cited by 56
Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation
Koyawala, N., Silber, J. H., Rosenbaum, P. R., Wang, W., Hill, A. S., Reiter, J. G., Niknam, B. A., Even‐Shoshan, O., Bloom, R. D., Sawinski, D. L., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016070768 · Cited by 55
Cutaneous Malignant Neoplasms in Hematopoietic Cell Transplant Recipients
DePry, J. L., Vyas, R., Lazarus, H. M., Caimi, P. F., Gerstenblith, M. R., & Bordeaux, J. S. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.121 · Cited by 54
Malignancy after Solid Organ Transplantation: Comprehensive Imaging Review
Katabathina, V. S., Menias, C. O., Tammisetti, V. S., Lubner, M. G., Kielar, A. Z., Shaaban, A. M., Mansour, J., Surabhi, V. R., & Hara, A. K. (2016) · Radiographics · doi:10.1148/rg.2016150175 · Cited by 54
Survival Benefit in Renal Transplantation Despite High Comorbidity
Sørensen, V. R., Heaf, J. G., Wehberg, S., & Sørensen, S. S. (2015) · Transplantation · doi:10.1097/tp.0000000000001002 · Cited by 53
Sebaceous Carcinoma Epidemiology and Genetics: Emerging Concepts and Clinical Implications for Screening, Prevention, and Treatment
Sargen, M. R., Starrett, G. J., Engels, E. A., Cahoon, E. K., Tucker, M. A., & Goldstein, A. M. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2473 · Cited by 53
Self-citation
Mortality after lung transplantation: a single‐centre cohort analysis
Raskin, J., Vanstapel, A., Verbeken, E. K., Beeckmans, H., Vanaudenaerde, B. M., Verleden, S. E., Neyrinck, A., Ceulemans, L. J., Raemdonck, D. E. V., Verleden, G. M., et al. (2019) · Transplant International · doi:10.1111/tri.13540 · Cited by 52
Immunotherapy and Liver Transplantation: A Narrative Review of Basic and Clinical Data
Wassmer, C., Hajji, S. E., Papazarkadas, X., Compagnon, P., Tabrizian, P., Lacotte, S., & Toso, C. (2023) · Cancers · doi:10.3390/cancers15184574 · Cited by 52
Survival After Cutaneous Melanoma in Kidney Transplant Recipients: A Population-Based Matched Cohort Study
Vajdic, C. M., Chong, A. H., Kelly, P. J., Meagher, N. S., van Leeuwen, M. T., Grulich, A. E., & Webster, A. C. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12716 · Cited by 52
Liver Transplantation for Cholestatic Liver Diseases in Adults
Khungar, V., & Goldberg, D. S. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.08.011 · Cited by 52
De Novo Malignancies Following Liver Transplantation: Results From a Multicentric Study in Central and Southern Italy, 1990–2008
Ettorre, G. M., Piselli, P., Galatioto, L., Rendina, M. G., Nudo, F., Sforza, D., Miglioresi, L., Fantola, G., Cimaglia, C., Vennarecci, G., et al. (2013) · Transplantation Proceedings · doi:10.1016/j.transproceed.2013.07.050 · Cited by 51
The role of NFATc1 in prostate cancer progression: Cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion
Kawahara, T., Kashiwagi, E., Ide, H., Li, Y., Zheng, Y., Ishiguro, H., & Miyamoto, H. (2015) · The Prostate · doi:10.1002/pros.22937 · Cited by 54
Chronic Kidney Disease and Risk of Renal Cell Carcinoma
Hofmann, J. N., Corley, D. A., Zhao, W. K., Colt, J. S., Shuch, B. M., Chow, W., & Purdue, M. P. (2014) · Epidemiology · doi:10.1097/ede.0000000000000205 · Cited by 51

Authors: Engels, E. A., Pfeiffer, R. M., Fraumeni, J. F., Kasiske, B. L., Israni, A. K., Snyder, J. J., Wolfe, R. A., Goodrich, N. P., Bayakly, A. R., Clarke, C. A., Copeland, G., Finch, J. L., Fleissner, M. L., Goodman, M. T., Kahn, A., Koch, L., Lynch, C. F., Madeleine, M. M., Pawlish, K., Rao, C., Williams, M. A., Castenson, D., Curry, M., Parsons, R., Fant, G., & Lin, M.
Affiliations: National Institutes of Health (US)
Arbor Research Collaborative for Health (US)
Cancer Prevention Institute of California (US)
Michigan Department of Health and Human Services (US)
Connecticut Agricultural Experiment Station (US)
University of Hawaiʻi at Mānoa (US)
Illinois Department of Public Health (US)
University of Iowa (US)
Fred Hutch Cancer Center (US)
New Jersey Department of Health (US)
Texas Department of State Health Services (US)
Information Management Services (US)
United States Department of Health and Human Services (US)
Corresponding author: Engels, Eric A.
ORCID: Engels, Eric A.
Pfeiffer, Ruth M.
Kasiske, Bertram L.
Israni, Ajay K.
Snyder, Jon J.
Goodrich, Nathan P.
Clarke, Christina A.
Copeland, Glenn
Finch, Jack L.
Goodman, Marc T.
Kahn, Amy
Lynch, Charles F.
Madeleine, Margaret M.
Pawlish, Karen
Rao, Chandrika
Castenson, David
Curry, Michael
Fant, Gregory
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2011-11-02
Volume: 306
Issue: 17
Pages: 1891
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.2011.1592
PMC: PMC3310893
OpenAlex: W1964106115
Cited by: 1,524
References: 43
Citations by year: 2026: 83 · 2025: 100 · 2024: 100 · 2023: 89 · 2022: 106 · 2021: 114 · 2020: 134 · 2019: 124 · 2018: 107 · 2017: 114 · 2016: 108 · 2015: 106 · 2014: 97 · 2013: 83 · 2012: 55
FWCI: 37.37
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (n01pc54405-9-0-0, n01pc35143-20-0-1, n01pc35139-25-0-11, n01pc35142-19-0-0, n01pc35137-18-0-2)
National Cancer Institute (N01PC35139, HHSN261201000034 C, HHSN261201000036C, HHSN261201000035C, N01‐PC035137, N01 PC035143, N01 PC35142, HHSN261201000037C, N01-PC-54405, HHSN261201000035I, N01-PC-35 137, N01PC-35143, N01 PC035139, HHSN261201000024C, N01 PC035142, N01 PC054405, ZIACP010150)
National Center for Chronic Disease Prevention and Health Promotion (5U58DP000824-04, 5U58DP000812-03, U58 DP000812, U58 DP000817, U58 DP000805, U58 DP000807, U58 DP000848-04, U58 DP000832, 5U58DP000817-05, U58 DP000824, U58/DP000808, #1U58DP000807-01, 5658DP 000805-04, U58 DP000848, 5U58/DP000808-03)
Topics: Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
Keywords: solid organ transplant recipients, cancer risk, immunosuppression, non-Hodgkin lymphoma, lung cancer, Kaposi's sarcoma, anal cancer, melanoma, thyroid cancer, lip cancer, hepatitis C, cytomegalovirus, Epstein-Barr virus, post-transplant lymphoproliferative disorder
MeSH terms: Adolescent, Adult, Aged, Child, Child, Preschool, Female, Humans, Immune Tolerance, Infant, Male, Middle Aged, Neoplasms, Registries, Risk, United States, Cohort Studies, Incidence, Organ Transplantation, Immunocompromised Host, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks